Stemline Therapeutics Inc's

Name: Stemline Therapeutics Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

STML Sales vs. its Competitors Q1 2020

Comparing the current results to its competitors, Stemline Therapeutics Inc reported Revenue increase in the 1 quarter 2020 by 75.74 % year on year.
The sales growth was above Stemline Therapeutics Inc's competitors' average revenue growth of 71.72 %, achieved in the same quarter.

• List of STML Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Stemline Therapeutics Inc recorded a net loss, as well as most of its competitors.

<< STML Stock Performance Comparisons

<< See the full list of STML competitors

Overall company Market Share Q1 2020

Due to outstanding performance in Overall company, revenue grew by 75.74 % Stemline Therapeutics Inc has increased its market share in this segment. << More on STML Market Share.

*Market share is calculated based on total revenue.

STML's Stock Performance relative to its Competitors

Publicly Traded Peers of Stemline Therapeutics Inc

Vbi Vaccines Inc
Share Performance

-91.96%

30 Days

Vbi Vaccines Inc

Profile

Vbi Vaccines Inc is a biopharmaceutical company that focuses on the development and commercialization of a new generation of vaccines and immunotherapies. Their business model revolves around leveraging their proprietary technologies to create innovative products that target a range of infectious diseases and immune-oncology indications. By conducting rigorous research and clinical trials, Vbi Vaccines aims to bring these novel therapies to market and address unmet medical needs.

More about Vbi Vaccines Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1.475 mill.	$ 9.411 mill.	$ -83.990 mill.

Sources: Stemline Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Wednesday, September 2, 2026 7:43 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Stemline Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.